CUSIP NO. 449778109
|
Page 2 of 6 Pages
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Lundbeckfond Invest A/S
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Denmark
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
6,049,452 (1)
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0 |
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
6,049,452 (1) |
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0 |
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
6,049,452 (1) |
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
21.8% (2)
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
(1) |
The board of directors of Lundbeckfond Invest A/S, consisting of Steffen Kragh, Lars Holmqvist, Susanne Krüger Kjær, Michael Kjær, Peter Schütze, Gunhild Waldemar, Svend Andersen, Ludovic Tranholm Otterbein,
Vagn Flink Møller Pedersen and Kristian Funding Andersen, and Lene Skole, the chief executive officer of Lundbeckfond Invest A/S, may be deemed to share voting and investment authority over the shares held by Lundbeckfond Invest A/S. No
individual member of the board of directors of Lundbeckfond Invest A/S is deemed to hold any beneficial ownership in the shares held by Lundbeckfond Invest A/S.
|
(2) |
Based upon 27,742,767 shares of Common Stock expected to be outstanding upon closing of the Company’s IPO, as reported in the Company’s prospectus pursuant to Rule 424(b)(4) filed with the Securities and
Exchange Commission on November 8, 2021.
|
CUSIP NO. 449778109
|
Page 3 of 6 Pages
|
Item 1. |
Security and Issuer
|
Item 2. |
Identity and Background
|
(a) |
This Schedule 13D is filed by Lundbeckfond Invest A/S (the “Reporting Person”). The board of directors of Lundbeckfond Invest A/S, consisting of Steffen Kragh, Lars Holmqvist, Susanne Krüger Kjær, Michael
Kjær, Peter Schütze, Gunhild Waldemar, Svend Andersen, Ludovic Tranholm Otterbein, Vagn Flink Møller Pedersen and Kristian Funding Andersen, and Lene Skole, the chief executive officer of Lundbeckfond Invest A/S, may be deemed to share voting
and investment authority over the shares held by Lundbeckfond Invest A/S. Neither Lene Skole nor any individual member of the board of directors of Lundbeckfond Invest A/S is deemed to hold any beneficial ownership in the shares held by
Lundbeckfond Invest A/S.
|
(b) |
The business address of the Reporting Person and each of the natural persons identified in response to Item 2(a) is Scherfigsvej 7, DK-2100 Copenhagen, Denmark.
|
(c) |
Lundbeckfond Invest A/S is a private Danish corporation responsible for managing assets of the Lundbeck Foundation.
|
(d) |
Within the last five years, neither the Reporting Person nor any natural person identified in response to Item 2(a) has been convicted in any criminal proceedings.
|
(e) |
Within the last five years, neither the Reporting Person nor any natural person identified in response to Item 2(a) has been a party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
|
(f) |
The Reporting Person is incorporated in Denmark, and each of the natural persons identified in response to Item 2(a) are citizens of Denmark.
|
Item 3.
|
Source and Amount of Funds or Other Consideration
|
CUSIP NO. 449778109
|
Page 4 of 6 Pages
|
Item 4.
|
Purpose of Transaction
|
Item 5.
|
Interest in Securities of the Issuer
|
CUSIP NO. 449778109
|
Page 5 of 6 Pages
|
Item 6. |
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7. |
Material to be Filed as Exhibits.
|
Power of Attorney, dated as of November 19, 2021
|
|
Exhibit 99.2
|
Investors’ Rights Agreement, dated October 29, 2021 (incorporated by reference to Exhibit 10.13 to the Issuer’s registration statement on Form S-1, File No. 333-260301).
|
Exhibit 99.3:
|
Form of Lock-Up Agreement (incorporated by reference to Exhibit A to the Form of Underwriting Agreement filed as Exhibit 1.1 to the Issuer’s registration statement on Form S-1, File No. 333-260301)
|
CUSIP NO. 449778109
|
Page 6 of 6 Pages
|
LUNDBECKFOND INVEST A/S
|
|||
By:
|
/s/ Brian Burkavage
|
||
Name: | Brian Burkavage | ||
Title: | Attorney-in-Fact for Christian Elling, Managing Partner, and Lene Skole, Chief Executive Officer | ||
|
|||
Date: | November 19, 2021 |
(1) |
prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) or any rule
or regulation of the SEC;
|
(2) |
execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or
stockholder of IO Biotech, Inc., a Delaware corporation (the "Company"), all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Exchange Act and the rules and regulations thereunder, including, without limitation: (a) any
acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k) under the Exchange Act, and (c) any initial statements of, or statements of changes in,
beneficial ownership of securities on Form 3, Form 4 or Form 5 and any amendments thereto;
|
(3) |
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to
complete and execute any such Schedule 13D or 13G, joint filing agreement, or Form 3,
4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
|
(4) |
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
|
LUNDBECKFOND INVEST A/S
|
||
By:
|
/s/ Christian Elling
|
|
Christian Elling, Managing Partner
|
||
By:
|
/s/ Lene Skole
|
|
Lene Skole, Chief Executive Officer
|